Diseases, Free Full-Text

Colorectal cancer (CRC) is the third most common cancer worldwide. A diagnosis at early stages with enhanced screening methods is vital as metastases and recurrences increase mortality. The aim of this study was to analyze the tumor markers CEA and CA19-9 combined in correlation with diagnostics and prognosis. Therefore, 1487 patients with CRC who were diagnosed and treated between 2000 and 2015 at the University Hospital Ulm, Germany, were retrospectively evaluated. Overall and recurrence-free survival was analyzed in association with preoperative CEA and CA19-9 separately and combined and a multivariate analysis was performed. The 5-year overall survival was significantly shorter in patients with a CEA or CA19-9 level ≥200 compared to patients with an increased, but <200, or normal level (CEA: 69%/44%/7%; CA19-9: 66%/38%/8%). Patients with both tumor markers increased also showed a remarkably shorter 5-year survival rate (CEA+/CA19-9+: 23%). The multivariate analysis emphasizes these results (p-value < 0.0001). Patients with both tumor markers elevated had the shortest 5-year recurrence-free survival rate, followed by patients with either CEA or CA19-9 elevated (CEA-/CA19-9-: 79%; CEA+/CA19-9; CEA-/CA19-9+: 65%; CEA+/CA19-9+: 44%). In conclusion, measuring CEA and CA19-9 preoperatively in CRC patients is reasonable and could be useful as a prognostic factor.

Aging and aging-related diseases: from molecular mechanisms to interventions and treatments

Frontiers Management and Prevention Strategies for Non-communicable Diseases (NCDs) and Their Risk Factors

Gonadotropin Levels and Underlying Diseases in adults

Non-communicable Diseases - Types and Prevention

Viruses, Free Full-Text

The Anti-Aging Revolution: Break free from the chronic diseases and pain of aging with strategies that reverse aging, increase longevity, and enhance your lifespan. (English Edition) - eBooks em Inglês na

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet

Annals of Family Medicine

International Classification of Diseases (ICD)

Prevalence of access to treatment of chronic diseases in Brazil and

Return-to-Play for Elite Athletes With Genetic Heart Diseases Predisposing to Sudden Cardiac Death

Celiac Disease: Symptoms, Testing, Treatment & Research